Oral Genome Corp – Trademark Portfolio

Entity Type: 03

Oral Genome Corp holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include ORAL HEALTH ALLY and THE MOUTH EXPERTS. The owner is based in Carlsbad, CA.

7720 Rancho Santa Fe Rd Ste 225

Carlsbad, CA 92009

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Oral Genome Corp's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Oral Genome Corp have?

Oral Genome Corp has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending.

What trademark classes does Oral Genome Corp file in?

Oral Genome Corp files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Oral Genome Corp's most well-known trademarks?

Oral Genome Corp's registered trademark portfolio includes well-known marks such as ORAL HEALTH ALLY and THE MOUTH EXPERTS. These are among 2 currently registered trademarks in the portfolio.

What is Oral Genome Corp's trademark registration success rate?

Oral Genome Corp has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.